Dosage & Administration Biomarker testing Drug label Prior authorization Financial assistance

Yondelis

(trabectedin)

Yondelis 1 MG Injection

NO BOXED WARNING

Dosage & administration

* Administer at 1.5 mg/m2 body surface area as a 24-hour intravenous infusion, every 3 weeks through a central venous line
* Premedication: dexamethasone 20 mg intravenously, 30 min before each infusion
* Hepatic Impairment: Administer at 0.9 mg/m2 body surface area as a 24-hour intravenous infusion, every 3 weeks through a central venous line in patients with moderate hepatic impairment

biomarker testing

Yondelis clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Yondelis prescribing information

Contact Medical Science Liaison Report Adverse Event

prior authorization

Yondelis prior authorization resources

Most recent Yondelis prior authorization forms

View By Payer

Verified: Nov 27, 2023Cigna - Yondelis Prior Authorization Form

Complete Letter of Medical Necessity

Letter of Exception

Learn More

Benefits investigation

Yondelis Prescription & Medical Benefits Investigation Form

Learn More

financial assistance

Yondelis financial assistance options

Co-pay savings program

commercial only

Yondelis Prescription & Medical Benefits Investigation Form

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

under insured

no insurance

goverment insurance

65+

J&J Patient Assistance Program - Eligibility Check

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Yondelis patient education

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link